Ravikiran Bodlapati and Frank Burslem argue eligibility, access and uptake will decide how far GLP-1 sales can grow from today.
Recap by typeshit. Post by The Business Research Company on X.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
A ticketed talk in Bergen County on eating, moving and keeping muscle while on a GLP-1. Event promotion with little news in it.
Medscape reports strong weight loss results for teens on GLP-1 medications, while noting there's still little data on long-term effects or growth.
Loading…